298 related articles for article (PubMed ID: 25763723)
1. Infiltrative hepatocellular carcinoma: what radiologists need to know.
Reynolds AR; Furlan A; Fetzer DT; Sasatomi E; Borhani AA; Heller MT; Tublin ME
Radiographics; 2015; 35(2):371-86. PubMed ID: 25763723
[TBL] [Abstract][Full Text] [Related]
2. Using Gd-EOB-DTPA-enhanced 3-T MRI for the differentiation of infiltrative hepatocellular carcinoma and focal confluent fibrosis in liver cirrhosis.
Park YS; Lee CH; Kim BH; Lee J; Choi JW; Kim KA; Ahn JH; Park CM
Magn Reson Imaging; 2013 Sep; 31(7):1137-42. PubMed ID: 23688409
[TBL] [Abstract][Full Text] [Related]
3. Benign and malignant mimickers of infiltrative hepatocellular carcinoma: tips and tricks for differential diagnosis on CT and MRI.
Vernuccio F; Porrello G; Cannella R; Vernuccio L; Midiri M; Giannitrapani L; Soresi M; Brancatelli G
Clin Imaging; 2021 Feb; 70():33-45. PubMed ID: 33120287
[TBL] [Abstract][Full Text] [Related]
4. Diffuse infiltrative hepatocellular carcinoma: Multimodality imaging manifestations.
Madani SP; Mirza-Aghazadeh-Attari M; Mohseni A; Pawlik T; Kamel IR
J Surg Oncol; 2023 Mar; 127(3):385-393. PubMed ID: 36374195
[TBL] [Abstract][Full Text] [Related]
5. Imaging of hepatocellular carcinoma: practical guide to differential diagnosis.
Anis M; Irshad A
Clin Liver Dis; 2011 May; 15(2):335-52, vii-x. PubMed ID: 21689617
[TBL] [Abstract][Full Text] [Related]
6. Detection of primary hepatic malignancy in liver transplant candidates: prospective comparison of CT, MR imaging, US, and PET.
Teefey SA; Hildeboldt CC; Dehdashti F; Siegel BA; Peters MG; Heiken JP; Brown JJ; McFarland EG; Middleton WD; Balfe DM; Ritter JH
Radiology; 2003 Feb; 226(2):533-42. PubMed ID: 12563151
[TBL] [Abstract][Full Text] [Related]
7. Small (≤1-cm) hepatocellular carcinoma: diagnostic performance and imaging features at gadoxetic acid-enhanced MR imaging.
Yu MH; Kim JH; Yoon JH; Kim HC; Chung JW; Han JK; Choi BI
Radiology; 2014 Jun; 271(3):748-60. PubMed ID: 24588677
[TBL] [Abstract][Full Text] [Related]
8. Evidence of diagnostic enhancement pattern in hepatocellular carcinoma nodules ≤2 cm according to the AASLD/EASL revised criteria.
Quaia E; De Paoli L; Angileri R; Pizzolato R; Cabibbo B; Cova MA
Abdom Imaging; 2013 Dec; 38(6):1245-53. PubMed ID: 24026173
[TBL] [Abstract][Full Text] [Related]
9. [Imaging findings of fibrolamellar hepatocellular carcinoma].
Wang M; Cui Z; Yu G
Zhonghua Zhong Liu Za Zhi; 1999 Mar; 21(2):128-30. PubMed ID: 11776854
[TBL] [Abstract][Full Text] [Related]
10. Arterial enhancing-only nodules less than 2 cm in diameter in patients with liver cirrhosis: predictors of hepatocellular carcinoma diagnosis on gadobenate dimeglumine-enhanced MR imaging.
Quaia E; Pizzolato R; De Paoli L; Angileri R; Ukmar M; Cova MA
J Magn Reson Imaging; 2013 Apr; 37(4):892-902. PubMed ID: 23097278
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma of diffuse type: MR imaging findings and clinical manifestations.
Kanematsu M; Semelka RC; Leonardou P; Mastropasqua M; Lee JK
J Magn Reson Imaging; 2003 Aug; 18(2):189-95. PubMed ID: 12884331
[TBL] [Abstract][Full Text] [Related]
12. Cholangiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma.
Rimola J; Forner A; Reig M; Vilana R; de Lope CR; Ayuso C; Bruix J
Hepatology; 2009 Sep; 50(3):791-8. PubMed ID: 19610049
[TBL] [Abstract][Full Text] [Related]
13. Contrast-enhanced ultrasound of hepatocarcinogenesis in liver cirrhosis.
Wu W; Chen MH; Sun M; Yan K; Yang W; Li JY
Chin Med J (Engl); 2012 Sep; 125(17):3104-9. PubMed ID: 22932189
[TBL] [Abstract][Full Text] [Related]
14. Probability of hepatocellular carcinoma of small hepatocellular nodules undetectable by computed tomography during arterial portography.
Tanaka Y; Sasaki Y; Katayama K; Hiramatsu N; Ito A; Murata H; Enomoto N; Oshita M; Mochizuki K; Tsujii M; Tsuji S; Kasahara A; Tomoda K; Nakamura H; Hayashi N; Hori M
Hepatology; 2000 Apr; 31(4):890-8. PubMed ID: 10733545
[TBL] [Abstract][Full Text] [Related]
15. Focal nodular hyperplasia or focal nodular hyperplasia-like lesions of the liver: a special emphasis on diagnosis.
Choi JY; Lee HC; Yim JH; Shim JH; Lim YS; Shin YM; Yu ES; Suh DJ
J Gastroenterol Hepatol; 2011 Jun; 26(6):1004-9. PubMed ID: 21251063
[TBL] [Abstract][Full Text] [Related]
16. Benign nodules in post-Fontan livers can show imaging features considered diagnostic for hepatocellular carcinoma.
Wells ML; Hough DM; Fidler JL; Kamath PS; Poterucha JT; Venkatesh SK
Abdom Radiol (NY); 2017 Nov; 42(11):2623-2631. PubMed ID: 28785785
[TBL] [Abstract][Full Text] [Related]
17. Early advanced hepatocellular carcinoma: evaluation of CT and MR appearance with pathologic correlation.
Winter TC; Takayasu K; Muramatsu Y; Furukawa H; Wakao F; Koga H; Sakamoto M; Hirohashi S; Freeny PC
Radiology; 1994 Aug; 192(2):379-87. PubMed ID: 8029401
[TBL] [Abstract][Full Text] [Related]
18. Imaging findings of mimickers of hepatocellular carcinoma.
Kim TK; Lee E; Jang HJ
Clin Mol Hepatol; 2015 Dec; 21(4):326-43. PubMed ID: 26770920
[TBL] [Abstract][Full Text] [Related]
19. Imaging study of early hepatocellular carcinoma: usefulness of gadoxetic acid-enhanced MR imaging.
Sano K; Ichikawa T; Motosugi U; Sou H; Muhi AM; Matsuda M; Nakano M; Sakamoto M; Nakazawa T; Asakawa M; Fujii H; Kitamura T; Enomoto N; Araki T
Radiology; 2011 Dec; 261(3):834-44. PubMed ID: 21998047
[TBL] [Abstract][Full Text] [Related]
20. Imaging diagnosis.
Lencioni R; Cioni D; Della Pina C; Crocetti L; Bartolozzi C
Semin Liver Dis; 2005; 25(2):162-70. PubMed ID: 15918145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
